IP Library › Granted Patent US 12,364,810
Granted Patent B2
US 12,364,810 · App. 18/457,394 · Granted Jul 22, 2025

Drug delivery device with needle actuation mechanism

Inventors: Oliver Wieser (Zürich, CH); Maximilian Marhöfer (Basel, CH)
Assignee: SENSILE MEDICAL AG
A61M5/158A61M5/14212A61M5/3221A61M2005/1585A61M2005/3224
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,364,810
App. No.
18/457,394
Granted
Jul 22, 2025
Kind
B2
Abstract

A drug delivery device ( 1 ) comprising a delivery unit ( 2 ) receiving a drug cartridge ( 3 ) containing a drug to be administered to a patient in need thereof, the delivery unit comprising a subcutaneous delivery mechanism ( 7 ) including a needle ( 24 ), a needle support ( 8 ) to which the needle is mounted, and a needle actuation mechanism ( 9 ) configured to move the needle from a retracted position within a housing ( 5 ) of the delivery unit ( 2 ), to an extended delivery position where the needle projects through a base wall ( 14 ) of the housing. The needle actuation mechanism comprises a rotary actuator ( 10 ) configured to engage an engagement lever ( 11 ) coupled to the needle support ( 8 ) for translating the needle support between retracted and extended delivery positions.

Claims (20)

1. A drug delivery device comprising a delivery unit receiving a drug cartridge containing a drug to be administered to a patient in need thereof, the delivery unit comprising a subcutaneous delivery mechanism including a needle, a needle support to which the needle is mounted, and a needle actuation mechanism configured to move the needle from a retracted position within a housing of the delivery unit, to an extended delivery position where the needle projects through a base wall of the housing, the needle actuation mechanism comprising a rotary actuator configured to engage an engagement lever coupled to the needle support for translating the needle support between the retracted position and the extended delivery position, wherein the needle support comprises a translation guide member slidably mounted with respect to the housing, and a rotation guide member rotatably mounted to the translation guide member, the needle being fixed to the rotation guide member configured to tilt the needle in a fully retracted park position after full retraction of the needle, and the delivery unit comprising a mounting surface with an adhesive layer on an underside of the base wall from mounting against a patient's skin.

2. The device according to claim 1 , wherein the engagement lever is pivotally mounted on the needle support and elastically engages the needle support configured to allow the engagement lever to elastically pivot and bias against the rotary actuator of the needle actuation mechanism in the extended delivery position such that the rotary actuator may turn freely in a delivery direction (R+).

3. The device according to claim 1 , wherein the rotary actuator is coupled directly to a rotor of a pump module mounted in the delivery unit.

4. The device according to claim 3 , wherein the rotary actuator is integrally formed with the rotor of the pump module.

5. The device according to claim 3 , wherein the rotation guide member of the needle support comprises a liquid channel therein interconnecting a liquid delivery conduit connected to an outlet of the pump module to the needle.

6. The device according to claim 1 , wherein the rotary actuator comprises a disc shape with an outer peripheral rim comprising a catch formed by a recess in the rim for engaging an engagement end of the engagement lever.

7. The device according to claim 1 , wherein the engagement lever comprises a suspension engaging the needle support allowing elastic pivoting of the engagement lever relative to the needle support.

8. The device according to claim 1 , wherein the rotation guide member comprises a cylindrical body portion rotatably mounted in a rotation member support of the translation guide member.

9. The device according to claim 1 , wherein the engagement lever comprises a protuberance on a lower side of an engagement end configured for catching on a lower catch edge of the rotary actuator when it moves in a reverse direction (R−).

10. The device according to claim 1 , wherein the engagement lever comprises a pivot portion and an engagement arm extending from the pivot portion to an engagement end, the pivot portion being mounted on a pivot support extending from the rotation guide member of the needle support.

11. The device according to claim 1 , wherein the rotation guide member of the needle support comprises an anti-rotation guide surface slidably engaging a complementary anti-rotation guide surface extending from the housing base wall configured for preventing rotation of the rotation guide member when travelling between the retracted position and the extended delivery position, the anti-rotation surfaces arranged to disengage in the fully retracted park position when the rotary actuator is rotated in a reverse direction to allow tilting of the needle into the fully retracted park position preventing further reuse of the needle.

12. The device according to claim 1 , wherein the rotary actuator comprises a drive interface configured for coupling to a pump drive mounted in a base unit comprising an electronic control system, a power source and said pump drive for actuation of the rotary actuator.

13. The device according to claim 1 , wherein the delivery unit is formed as a disposable part containing said drug cartridge in the housing of the delivery unit, and a base unit formed as a reusable part comprising an electronic control system, a power source, and a pump drive, the base unit being removable mountable to the delivery unit.

14. The device according to claim 1 , comprising a locking element engaging a tip of the needle in the fully retracted park position to block the needle in the fully retracted park position.

15. The device according to claim 14 , wherein the locking element comprises a locking nest filled with a soft material into which the tip of the needle buries when moving into the fully retracted park position.

16. The device according to claim 14 , wherein the locking element comprises a locking protrusion provided with a tapered surface to guide the needle tip over the locking protrusion.

17. A drug delivery device comprising a delivery unit receiving a drug cartridge containing a drug to be administered to a patient in need thereof, the delivery unit comprising a subcutaneous delivery mechanism including a needle, a needle support to which the needle is mounted, and a needle actuation mechanism configured to move the needle from a retracted position within a housing of the delivery unit, to an extended delivery position where the needle projects through a base wall of the housing, the needle actuation mechanism comprising a rotary actuator configured to engage an engagement lever coupled to the needle support for translating the needle support between the retracted position and the delivery position, wherein the needle support comprises a pivot support and the engagement lever comprises a pivot portion rotatably mounted around a rotation axis wherein the rotation axis is on the pivot support, wherein the engagement lever is pivotally mounted on the needle support via the pivot portion and the pivot support such that said rotation axis is translated with said needle support, and wherein the engagement lever elastically engages the needle support configured to allow the engagement lever to elastically pivot and bias against the rotary actuator of the needle actuation mechanism in the extended delivery position such that the rotary actuator may turn freely in a delivery direction (R+).

18. The device according to claim 17 , wherein the rotary actuator is coupled directly to a rotor of a pump module mounted in the delivery unit.

19. The device according to claim 17 , wherein the rotary actuator comprises a disc shape with an outer peripheral rim comprising a catch formed by a recess in the rim for engaging an engagement end of the engagement lever.

20. The device according to claim 17 , wherein the engagement lever comprises a suspension engaging the needle support allowing elastic pivoting of the engagement lever relative to the needle support.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2023
From: WIESER, OLIVER; MARHÖFER, MAXIMILIAN
To: SENSILE MEDICAL AG
Reel/Frame 064734/0716 →
Priority Claims (1)
EP 18174647 · May 28, 2018 · regional
Continuity (2)
Continuation 17057728
Related Publication 20230398289A1 · Dec 14, 2023
References Cited (43)
US 7726955B2 · Ryser et al. · 2010 [cited by applicant]
US 8282366B2 · Hilber et al. · 2012 [cited by applicant]
US 8382700B2 · Straessler et al. · 2013 [cited by applicant]
US 8535269B2 · Scheurer et al. · 2013 [cited by applicant]
US 8957674B2 · Genoud et al. · 2015 [cited by applicant]
US 9222470B2 · Genoud et al. · 2015 [cited by applicant]
US 9302285B2 · Marbet et al. · 2016 [cited by applicant]
US 9662621B2 · Beyer et al. · 2017 [cited by applicant]
US 10076605B2 · Marbet et al. · 2018 [cited by applicant]
US 10143798B2 · Marbet et al. · 2018 [cited by applicant]
US 10632249B2 · Marbet et al. · 2020 [cited by applicant]
US 10954928B2 · Burli et al. · 2021 [cited by applicant]
US 11009018B2 · Wyss et al. · 2021 [cited by applicant]
US 11009026B2 · Girschweiler et al. · 2021 [cited by applicant]
US 11022107B2 · Brandt et al. · 2021 [cited by applicant]
US 11160922B2 · Just · 2021 [cited by applicant]
US 11612687B2 · Marbet · 2023 [cited by applicant]
US 11744940B2 · Wieser et al. · 2023 [cited by applicant]
US 20050215951A1 · Saulenas · 2005 [cited by examiner]
US 20090030382A1 · Brandt et al. · 2009 [cited by applicant]
US 20100241063A1 · Straessler et al. · 2010 [cited by applicant]
US 20120046651A1 · Beyer et al. · 2012 [cited by applicant]
US 20130338594A1 · Da Ros · 2013 [cited by examiner]
US 20140231549A1 · Thiemer et al. · 2014 [cited by applicant]
US 20160008537A1 · Lanigan · 2016 [cited by applicant]
US 20160184512A1 · Marbet · 2016 [cited by examiner]
US 20160213838A1 · Schabbach et al. · 2016 [cited by applicant]
US 20220031940A1 · Hulliger et al. · 2022 [cited by applicant]
US 20240033422A1 · Büchi et al. · 2024 [cited by applicant]
US 20240033423A1 · Muller et al. · 2024 [cited by applicant]
US 20240066541A1 · Perrier et al. · 2024 [cited by applicant]
US 20240082485A1 · Lagorgette et al. · 2024 [cited by applicant]
US 20240082486A1 · Lagorgette et al. · 2024 [cited by applicant]
US 20240091460A1 · Burli et al. · 2024 [cited by applicant]
US 20240157045A1 · Kostal et al. · 2024 [cited by applicant]
US 20240165325A1 · Burli · 2024 [cited by applicant]
US 20240173473A1 · Burli · 2024 [cited by applicant]
US 20240175431A1 · Mueller · 2024 [cited by applicant]
US 20240181153A1 · Kostal et al. · 2024 [cited by applicant]
US 20240226425A9 · Burli et al. · 2024 [cited by applicant]
WO WO2005039674 · 2005 [cited by applicant]
WO WO2015015379 · 2015 [cited by applicant]
Written Opinion in International Application No. PCT/EP2019/063269, Aug. 9, 2019, pp. 1-8. [cited by applicant]
Cited By (1)
US 12,691,217